Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Assistance Publique - Hôpitaux de Paris
Washington University School of Medicine
Prescient Therapeutics, Ltd.
City of Hope Medical Center
UNC Lineberger Comprehensive Cancer Center
University of Pittsburgh
University of Pittsburgh
Fondazione Italiana Linfomi - ETS
Fondazione Italiana Linfomi - ETS
Memorial Sloan Kettering Cancer Center
UNC Lineberger Comprehensive Cancer Center
National Cancer Institute (NCI)
City of Hope Medical Center
Assistance Publique - Hôpitaux de Paris
Kyowa Kirin Co., Ltd.
SciTech Development, Inc.
Kyowa Kirin Co., Ltd.
City of Hope Medical Center
City of Hope Medical Center
Icahn School of Medicine at Mount Sinai
Barbara Ann Karmanos Cancer Institute
Stanford University
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
Thomas Jefferson University
Washington University School of Medicine